ArticleScientific reports2026
Reproducible magnetophosphene thresholds induced by transcranial alternating magnetic stimulation in humans: a replication study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blue magnetophosphene perception under subthreshold magnetic stimulation in a human retinal degeneration model.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnetophosphenes, flickering visual percepts induced by extremely low-frequency magnetic fields (ELF-MF), represent the most sensitive and reproducible human response to induced electric fields and form a cornerstone of international exposure guidelines. Transcranial Alternating Magnetic Stimulation (tAMS), a recent non-invasive stimulation method, can elicit magnetophosphenes without scalp sensations, but its reliability and underlying mechanisms require replication for further validation. This replication study quantified magnetophosphene perception thresholds in 62 healthy participants exposed to sinusoidal magnetic fields (0-50 mT) at 20, 50, and 60 Hz. Three stimulation configurations were tested: retinal (RET), global head (GLO), and occipital (OCC). Perception probability was modeled using mixed-effects logistic regressions based on rate of change of magnetic flux density over time (dB/dt) as the primary metric. tAMS robustly induced magnetophosphenes, reproducing the threshold patterns reported by Legros et al. (2024). RET and GLO exposures produced steep dose-response curves and low thresholds, whereas OCC stimulation yielded minimal effects. Thresholds were strongly frequency-dependent, with highest sensitivity at 20 Hz. Regression slopes from the original and replication datasets showed high concordance (r = 0.965), confirming reproducibility. The spatial and frequency profiles consistently support a retinal, rod-mediated origin of magnetophosphenes. This replication study validates tAMS as a reliable method for eliciting magnetophosphenes and confirms their retinal origin across exposure conditions. These results strengthen the use of magnetophosphene thresholds as a benchmark for ELF-MF safety standards and underscore the potential of tAMS as a precise, comfortable, and confound-free neuromodulation tool for future diagnostic and therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.